Background: The use of adjunctive intraoperative mitomycin C has consi
derably improved the success rate of glaucoma filtering surgery. Howev
er, the ideal concentration and exposure time of mitomycin C is unknow
n. The purpose of this study is to determine whether a satisfactory su
rgical outcome can be achieved with a tower incidence of adverse side
effects by using a shorter exposure time of mitomycin C than has been
recommended previously. Methods: Twenty-five eyes of 25 consecutive pa
tients who were considered to be at high risk for surgical failure bec
ause of their age (<55 years), previous failure of trabeculectomy, pre
vious cataract surgery, or traumatic glaucoma received a single intrao
perative application of mitomycin C (0.2 mg/ml for 2 minutes). They we
re case-matched with a group of 48 consecutive patients who received a
single intraoperative application of mitomycin C (0.2 mg/ml for 5 min
utes) by using age, race, type of refractory glaucoma, and preoperativ
e intraocular pressure (IOP) as variables. Results: Eighteen months af
ter surgery, 22 (88%) patients in the 2-minute group and 21 (84%) pati
ents in the 5-minute group had an IOP less than 21 mmHg with or withou
t treatment. No significant differences were found in the complication
rate: in 2 (8%) of 25 eyes of the 2-minute group, chronic hypotony de
veloped compared with 3 (12%) of 25 eyes in the 5-minute group. Hypoto
ny-related maculopathy developed in one eye in the 5-minute group. A c
ystic bleb was found in 15 (60%) eyes in the 2-minute group compared w
ith 19 (76%) eyes in the 5-minute group, although this difference was
not statistically significant. Two (8%) eyes in the 2-minute group and
one eye (4%) in the 5-minute group had a bleb-related infection. In o
ne (4%) patient in each group, late severe endophthalmitis developed.
Conclusion: These results suggest that a 2-minute intraoperative appli
cation of 0.2 mg/ml mitomycin C is as effective as a 5-minute exposure
, but the complication rate remains unaltered.